MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ONC had $1,471,795K increase in cash & cash equivalents over the period. $561,916K in free cash flow.

Cash Flow Overview

Change in Cash
$1,471,795K
Free Cash flow
$561,916K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
Net income (loss)
220,431
Depreciation and amortization expense
105,702
Share-based compensation expenses
387,096
Acquired in-process research and development
691
Amortization of research and development cost share liability
-74,844
Impairment of equity investments
34,216
Other items, net
9,595
Accounts receivable
167,294
Inventories
22,662
Other assets
-55,247
Accounts payable
-7,381
Accrued expenses and other payables
165,886
Other liabilities
3,550
Net cash provided by (used in) operating activities
710,233
Purchases of property, plant and equipment
148,317
Purchase of intangible asset
20,000
Proceeds from sale or maturity of investments
1,800
Purchase of in-process research and development
60,691
Other investing activities
10,612
Net cash used in investing activities
-237,820
Proceeds from other debt
885,000
Proceeds from long-term loan
0
Repayment of long-term loan
21,062
Proceeds from short-term loans
221,521
Repayment of short-term loans
275,782
Payments of withholding taxes from share-based awards
24,195
Proceeds from option exercises and employee share purchase plan
177,038
Other financing activities
0
Net cash provided by financing activities
962,520
Effect of foreign exchange rate changes, net
36,862
Net increase (decrease) in cash, cash equivalents, and restricted cash
1,471,795
Cash and cash equivalents at beginning of period
2,638,747
Cash and cash equivalents at end of period
4,110,542
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

BeOne Medicines Ltd. (ONC)

BeOne Medicines Ltd. (ONC)